Tools
Results 21 - 30 of about 68
Original articles in indexed journals - GPCR Drug Discovery
Ghosh E, Dwivedi H, Baidya M, Srivastava A, Kumari P, Stepniewski T, Kim HR, Lee MH, van Gastel J, Chaturvedi M, Roy D, Pandey S, Maharana J, Guixà-González R, Luttrell LM, Chung KY, Dutta S, Selent J, Shukla AK. Conformational Sensors and Domain Swapping Reveal Structural and Functional Differences between β-Arrestin Isoforms. Cell Rep 2019; 28(13): 3287-3299.e6. PMID: 31553900 . DOI: 10.1016/j.celrep.2019.08.053.
2019
Original articles in indexed journals - GPCR Drug Discovery
Abraham MJ, Apostolov RP, Barnoud J, Bauer P, Blau C, Bonvin AMJJ, Chavent M, Chodera JD, Condic-Jurkic K, Delemotte L, Grubmüller H, Howard RJ, Jordan EJ, Lindal E, Ollila OHS, Selent J, Smith DGA, Stansfeld PJ, Tiemann JKS, Trellet M, Woods CJ, Zhmurov A. Sharing Data from Molecular Simulations. J Chem Inf Model. 2019. PMID: 31525920 . DOI: 10.1021/acs.jcim.9b00665.
2019
Original articles in indexed journals - GPCR Drug Discovery
Karoussiotis C, Martí-Solano M, Stepniewski T, Symeonof A, Selent J, Georgoussi Z. A highly conserved δ‐opioid receptor region determines RGS4 interaction. FEBS J, 2019. PMID: 31386272 . DOI: 10.1111/febs.15033.
2019
Original articles in indexed journals - GPCR Drug Discovery
Sánchez-Melgar A, Albasanz JL*, Guixà-González R, Saleh N, Selent J, Martín M. The antioxidant resveratrol acts as a non-selective adenosine receptor agonist. Free Radical Biol Med, 2019; 135: 261-273.. PMID: 30898665 . DOI: 10.1016/j.freeradbiomed.2019.03.019.
2019
Original articles in indexed journals - GPCR Drug Discovery
Stepniewski TM, Torrens-Fontanals M, Rodríguez – Espigares I, Giorgino T, Primdahl KG, Vik A, Stenstrøm Y, Selent J, Hansen TV. Synthesis, molecular modelling studies and biological evaluation of new oxoeicosanoid receptor 1 agonists. Bioorgan Med Chem, 2018; 26, 12: 3580-3587. PMID: 29866479 . DOI: 10.1016/j.bmc.2018.05.036.
2018
Original articles in indexed journals - GPCR Drug Discovery
Kaczor AA, Bartuzi D, Stepniewski TM, Matosiuk D, Selent J. Protein-Protein Docking in Drug Design and Discovery. Methods Mol Biol, 2018; 1762: 285-305. PMID: 29594778 . DOI: 10.1007/978-1-4939-7756-7_15.
2018
Original articles in indexed journals - GPCR Drug Discovery
Oddi S, Totaro A, Scipioni L, Dufrusine B, Stepniewski TM, Selent J, Maccarrone M, Dainese E. Role of palmitoylation of cysteine 415 in functional coupling CB1 receptor to Gαi2 protein. Biotechnol Appl Bioc, 2018; 65: 16-20. PMID: 28722168 . DOI: 10.1002/bab.1575.
2018
Original articles in indexed journals - GPCR Drug Discovery
Ramírez-Anguita JM, Rodríguez-Espigares I, Guixà-González R, Bruno A, Varela-Rial A, Selent J. Membrane cholesterol effect on the 5-HT2A receptor: Insights into the lipid-induced modulation of an antipsychotic drug target. Biotechnol Appl Bioc, 2018; 65(1): 29-37. PMID: 28877377 . DOI: 10.1002/bab.1608.
2018
Original articles in indexed journals - GPCR Drug Discovery
Iglesias A, Cimadevila M, la Fuente RA, Martí-Solano M, Cadavid MI, Cadavid MI, Selent J, Loza MI, Brea J. Serotonin 2A receptor disulfide bridge integrity is crucial for ligand binding to different signalling states but not for its homodimerization. Eur J Pharmacol, 2017 . PMID: 28899696 . DOI: 10.1016/j.ejphar.2017.09.011.
2017
Original articles in indexed journals - GPCR Drug Discovery
Azuaje J, López P, Iglesias A, de la Fuente RA, Pérez-Rubio JM, García D, Stępniewski TM, García-Mera X, Brea JM, Selent J, Pérez D, Castro M, Loza MI, Sotelo E. Development of Fluorescent Probes that Target Serotonin 5-HT2B Receptors. Sci Rep, 2017; 7 (1): 10765 . PMID: 28883627 . DOI: 10.1038/s41598-017-11370-2.
2017
